Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of IV Pantoprazole in Pediatric Patients
NCT02401035Phase 4Terminated
- Sponsor
- Pfizer
- Start
- May 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 4 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Pfizer. Started May 2017; status: terminated.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02401035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401035.